David McKillop
AstraZeneca (United Kingdom)(GB)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Pharmacogenetics and Drug Metabolism, Lung Cancer Treatments and Mutations, Microtubule and mitosis dynamics, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase(2007)273 cited
- → Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol(2005)155 cited
- → Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor(2005)125 cited
- → Mutagenicity, carcinogenicity and toxicity of β-naphthoflavone, a potent inducer of P448(1991)44 cited
- → Effects of phenobarbitone and β-naphthoflavone on hepatic microsomal drug metabolising enzymes of the male beagle dog(1985)19 cited
- → Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes(1981)18 cited
- → Nadh synergism of microsomal aniline metabolism in the presence of enhancing agents(1977)16 cited
- → Antioxidant status of oral mucosal tissue and plama levels in smokers and non‐smokers(1999)13 cited
- → Absence of hepatic enzyme induction in prostate cancer patients receiving `Casodex' (bicalutamide)(1996)11 cited
- → The Metabolism and Binding of Catecholamines by the Hepatic Microsomal Fraction of the Rat(1976)2 cited